|

Fr1da Early Diagnosis and Care of Type 1 Diabetes

RECRUITINGSponsored by Helmholtz Zentrum München
Actively Recruiting
SponsorHelmholtz Zentrum München
Started2015-02
Est. completion2028-12
Eligibility
Age2 Years – 10 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT04039945

Summary

The Fr1da study: "Early diagnosis and care of type 1 diabetes" aims to carry out a comprehensive, population-based screening for the early diagnosis of type 1 diabetes as part of the U7 to U11 preventive medical check-up for children or between the ages of 2 and 10 years in Bavaria and to implement it in other federal states. Screening is recommended at two time points: 1st screening at the age of 3 years (U7a) and 2nd screening at the age of 7 years (U10). In addition, relatives of patients with type 1 diabetes between the ages of 1 and 21 can be screened repeatedly at intervals of 3 to 5 years for an early-stage of type 1 diabetes.

Eligibility

Age: 2 Years – 10 YearsHealthy volunteers accepted
written informed consent by one custodial parent

Conditions2

DiabetesType 1 Diabetes Mellitus

Browse More Trials

Diabetes trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.